CLINICAL TRIALS SUCCESS STORY

Congratulations to Concorde Medical Group and Drs. Edward Brettholz and Alex Sherman (Principal Investigators) for their contributions to the research trial published in Gastroenterology 2010; 138:1286-129. ["Once-Daily Dosing of Delayed-Release Oral Mesalamine (400-mg Tablet) is as effective as Twice-Daily Dosing for Maintenance of Remission of Ulcerative Colitis"].